Sopan Pharmaceuticals Limited has opened its Initial Public Offering (IPO) from today (Chaitra 9) specifically for Nepalis working abroad.
The company has received approval to issue a total of 4,290,000 shares. In the first phase, 10% of these shares, i.e., 429,000 shares, have been reserved for Nepalis abroad with valid labor approval. Interested applicants can apply for a minimum of 10 shares and a maximum of 11,000 shares until Chaitra 12. If the full allotment is not received within this period, the application window will be extended until Chaitra 23.
The IPO is managed by NMB Capital Limited. Applications can be submitted online via the ‘Mero Share’ platform or through C-ASBA member banks and financial institutions.
CARE Ratings Nepal has assigned the company a ‘CARE NP B’ rating, indicating a high level of investment risk.
Out of the total shares, 5% have been reserved for collective investment funds and 4% for company employees. The remaining 3,474,900 shares will be issued to the general public at a later stage.
About the Author
